Obesity Clinic to Launch at Hiyoshi Diabetes and Internal Medicine Clinic (Yokohama City) from May 2026 | Medical Treatment by Diabetes Specialists | Self-Pay Service Using Weekly Self-Injectable "Zepbound"

Starting May 2026, the Hiyoshi Diabetes and Internal Medicine Clinic in Yokohama, Kanagawa, will launch an obesity outpatient clinic led by diabetes specialists. The clinic will offer a self-pay treatment using "Zepbound," a once-weekly self-injectable drug officially approved for obesity. The treatment is available for individuals aged 18 and over with a BMI of 22 or higher, after confirming they do not have diabetes. This initiative aims to extend patients' overall healthy lifespan through appropriate, evidence-based obesity treatment, while avoiding the off-label use of diabetes medications, which has become a recent issue.